Cytosorbents (CTSO) Total Debt (2016 - 2026)

Cytosorbents has reported Total Debt for 10 years, with the latest figure at $17.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 19.54% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (up 19.54% YoY), and the FY2025 full-year result was $16.7 million, up 19.08% from the prior year.
• Total Debt for Q1 2026 stood at $17.0 million, up from $16.7 million in the prior quarter.
• The five-year high for Total Debt was $17.0 million in Q1 2026, with the low at $4.4 million in Q1 2024.
• Historically, Total Debt has averaged $11.0 million across 5 years, with a median of $13.8 million in 2024.
• Annual changes were most pronounced in 2023 — Total Debt increased 0.86% — and 2025, when it soared 220.35%.
• Cytosorbents' Total Debt stood at $5.0 million in 2022, then increased by 0.86% to $5.0 million in 2023, then jumped by 177.54% to $14.0 million in 2024, then gained by 19.08% to $16.7 million in 2025, then advanced by 1.75% to $17.0 million in 2026.
• The last three Total Debt figures came in at $17.0 million (Q1 2026), $16.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.